Author Question: When caring for a patient with a secondary immunodeficiency disease following kidney transplantation ... (Read 68 times)

savannahhooper · **on:** Jul 23, 2018

When caring for a patient with a secondary immunodeficiency disease following kidney transplantation being treated for candidemia the nurse can anticipate receiving an order for what medication?

A) Amphotericin B
B) Anidulafungin
C) Flucytosine
D) Butoconazole

Question 2

The biogenic amine theory of depression states that depression results from a deficiency of biogenic amines in key areas of the brain. Why might a deficiency of these biogenic amines exist?

A) A slowing of the action of the neurons may lead to their depletion.
B) Monoamine oxidase (MAO) strengthens the impact of biogenic amines.
C) The number or sensitivity of postsynaptic receptors may increase.
D) Norepinephrine may be depleted because biogenic amines feed off of loose particles of the neurotransmitter.

akudia · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

B
Feedback:
Anidulafungin (Eraxis) is used for the treatment of candidemia (infection of the bloodstream) and other forms of candidal infections, intra-abdominal infections, and esophageal candidiasis. Amphotericin B is not indicated in the treatment of candidemia. Flucytosine is indicated for the treatment of candidemia but is excreted primarily in the urine so would be contraindicated in a patient with a transplanted kidney. Butoconazole is a topical medication that would not be appropriate for use treating a systemic bloodborne fungal infection.

Answer to Question 2

C
Feedback:
The three reasons for depression according to the biogenic amine theory include (1) MAO may break down biogenic amine to be recycled or restored in the neuron. (2) Rapid fire of the neurons may lead to their depletion. (3) The number or sensitivity of postsynaptic receptors may increase, thus depleting neurotransmitter levels.